Fennec Pharmaceuticals (FENC) EPS (Diluted) (QoQ) (2010 - 2025)
Fennec Pharmaceuticals (FENC) EPS (Diluted) (QoQ) (2010 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Fennec Pharmaceuticals | 346.75 Mn | 309.97 Mn | 12.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -638.44% |
| Sep 30, 2025 | 80.41% |
| Jun 30, 2025 | -170.21% |
| Mar 31, 2025 | 23.25% |
| Dec 31, 2024 | 73.64% |
| Sep 30, 2024 | -3.31% |
| Jun 30, 2024 | -148.65% |
| Mar 31, 2024 | 521.35% |
| Dec 31, 2023 | -47.95% |
| Sep 30, 2023 | 67.23% |
| Jun 30, 2023 | 9.44% |
| Mar 31, 2023 | 12.35% |
| Dec 31, 2022 | 16.98% |
| Sep 30, 2022 | -58.84% |
| Jun 30, 2022 | -40.49% |
| Mar 31, 2022 | 99.92% |
| Dec 31, 2021 | -100,876.60% |
| Sep 30, 2021 | -6.34% |
| Jun 30, 2021 | 19.30% |
| Mar 31, 2021 | 99.99% |